Biosight

Biotech & Life Sciences · Lod, Israel · Founded 2000

Biosight Pharma is a private, clinical-stage biotech company focused on developing innovative therapeutics for hematological malignancies and disorders. The company primarily serves patients with life-threatening diseases such as acute myeloid leukemia (AML), particularly targeting older patients who are unfit for standard chemotherapy. Operating in the oncology and hematology markets, Biosight Pharma's business model revolves around the research, development, and clinical trials of novel drug candidates. The company's lead product, BST-236 (aspacytarabine), is an advanced anti-metabolite designed to enable high-dose therapy with reduced systemic toxicity, aiming to provide safer and more effective treatment options. Revenue generation is expected through the successful commercialization of its drug candidates, either independently or through partnerships with larger pharmaceutical companies. Keywords: AML, acute myeloid leukemia, chemotherapy, clinical trial, hematology, innovative, oncology, prodrugs, biotech, therapeutics.

Valuation $100–500M

Headcount <100

Total funding $50–100M

Unlock exact values

Investors

7 investors on Biosight's cap table

Sourced from Dealroom's funding history.

Series B+ 7 investors entered at this stage

Primera Capital

Michael Ilan Management and Investments

Arkin Capital

Israel Biotech Fund

SBI Japan-Israel Innovation Fund

Migdal Insurance and Financial Holdings

The Phoenix Company

Global footprint

Where Biosight has talent and traffic

Workforce by country

1 countries with
team presence

🇮🇱 Israel100%

1 country shown

Talent graph

The shape of Biosight's talent

Dealroom maps Biosight's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

4 team members profilednamed & role-tagged by Dealroom

3 employeestotal headcount

1 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Biosight's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Biosight

An AI-synthesized read of the highest-engagement posts about Biosight on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biosight on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles